CRBP logo

Corbus Pharmaceuticals Holdings, Inc.

CRBP
Healthcare|Biotechnology|US
$3.07
+0.21 (+7.34%)
DCF Value
$1.97
Tangible Book / Share
$5.27
Cash / Share
$6.08
Next Earnings Report
Nov 11, 2026
EPS est. -$1.27 · Revenue est. $1.7M
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Aug 7, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Jan 2027
Est. completion
P1P2Solid Tumor, Adult
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
NCT06265727n=348
Dec 2027
Est. completion
P3Oropharyngeal Carcinoma (OPC)
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
NCT07768189n=260

Recent Press Releases

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in November
Nov 5, 2026 · GlobeNewsWire
Corbus Pharmaceuticals to Present Late Breaking CRB-913 Data from Canyon-1 Study at Obesity Week® 2026
Oct 22, 2026 · GlobeNewsWire
Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer
Sep 29, 2026 · GlobeNewsWire
Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity
Sep 14, 2026 · GlobeNewsWire
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
Sep 11, 2026 · GlobeNewsWire
Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 17, 2026 · GlobeNewsWire

SEC Filings (71)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 2, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 29, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 15, 20268-KMaterial eventDocumentIndex
Sep 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 14, 20268-KMaterial eventDocumentIndex
Aug 7, 2026424B5Offering prospectusDocumentIndex
Aug 6, 202610-QQuarterly reportDocumentIndex
Aug 6, 20268-KMaterial eventDocumentIndex
Jul 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 6, 20268-KMaterial eventDocumentIndex
Jun 17, 2026S-8Employee stock planDocumentIndex
May 29, 2026S-8Employee stock planDocumentIndex
May 26, 20268-KMaterial eventDocumentIndex
May 21, 20268-KMaterial eventDocumentIndex
May 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
May 12, 202610-QQuarterly reportDocumentIndex
May 12, 20268-KMaterial eventDocumentIndex
Apr 16, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 16, 20268-KMaterial eventDocumentIndex
Apr 14, 20268-KMaterial eventDocumentIndex
Apr 7, 20268-KMaterial eventDocumentIndex
Apr 2, 2026ARSAnnual report to holdersDocumentIndex
Apr 2, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 2, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 25, 2026424B3Offering prospectusDocumentIndex
Mar 20, 2026EFFECTDocumentIndex
Mar 11, 2026S-3Shelf registrationDocumentIndex
Mar 9, 202610-KAnnual reportDocumentIndex
Mar 9, 20268-KMaterial eventDocumentIndex
Feb 25, 20268-KMaterial eventDocumentIndex
Feb 10, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Dec 18, 20258-KMaterial eventDocumentIndex
Dec 15, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Dec 11, 20258-KMaterial eventDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 12, 2025SC 13GPassive 5%+ stakeDocumentIndex